Although great efforts in understanding the mechanisms underlying acute myeloid leukaemia (AML) have resulted in better diagnosis of the disease, attempts to improve its current treatment — a [...]
A multi-institutional academic and industry research team led by investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute has identified a promising new… [...]
Researchers at Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute (HSCI) have identified a drug compound that arrests in mice the progression of acute myeloid leukemia [...]
